These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33841683)

  • 1. Comparison of self-expandable stents and balloon-mounted stents in the treatment of symptomatic intracranial vertebral artery atherosclerotic stenosis.
    Tian C; Liu B; Liu J; Hong B; Zhao P; Yang L; Li Q; Yang Z
    Am J Transl Res; 2021; 13(3):1607-1616. PubMed ID: 33841683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of BMSs with SES for symptomatic intracranial disease of the middle cerebral artery stenosis.
    Yue X; Yin Q; Xi G; Zhu W; Xu G; Zhang R; Zhou Z; Ma M; Jin G; Liu X
    Cardiovasc Intervent Radiol; 2011 Feb; 34(1):54-60. PubMed ID: 20458585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balloon-mounting stent for intracranial arterial stenosis: A comprehensive and comparative systematic review and meta-analysis.
    Abdollahifard S; Yousefi O; Kamran H; Mowla A
    Interv Neuroradiol; 2023 Aug; 29(4):466-480. PubMed ID: 35549530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of self-expanding stents with distal embolic protection to balloon-expandable stents without a protection device in the treatment of symptomatic vertebral artery origin stenosis: a prospective randomized trial.
    Geng X; Hussain M; Du H; Zhao L; Chen J; Su W; Ma L; Gao Z; Ding Y; Ji X
    J Endovasc Ther; 2015 Jun; 22(3):436-44. PubMed ID: 25862360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications and long-term in-stent restenosis of endovascular treatment of severe symptomatic intracranial atherosclerotic stenosis and relevant risk factors.
    Yang L; Du H; Zhang D; Qiao Z; Su X; Han S; Gao BL; Cao Q
    Medicine (Baltimore); 2023 Sep; 102(38):e34697. PubMed ID: 37747021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thirty-Day Outcome of a Multicenter Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China.
    Miao Z; Zhang Y; Shuai J; Jiang C; Zhu Q; Chen K; Liu L; Li B; Shi X; Gao L; Liu Y; Wang F; Li Y; Liu T; Zheng H; Wang Y; Wang Y;
    Stroke; 2015 Oct; 46(10):2822-9. PubMed ID: 26286544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.
    Rathore S; Kinoshita Y; Terashima M; Katoh O; Matsuo H; Tanaka N; Kimura M; Tsuchikane E; Nasu K; Ehara M; Asakura K; Asakura Y; Suzuki T
    EuroIntervention; 2010 Feb; 5(7):841-6. PubMed ID: 20142201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of balloon-mounted stent in the treatment of symptomatic intracranial atherosclerotic disease: a multicenter experience.
    Mohammaden MH; Nogueira RG; Tekle W; Ortega-Gutierrez S; Farooqui M; Zevallos CB; Hanel RA; Cortez GM; Aghaebrahim A; Starke RM; Aref H; Elbassiouny A; Gamea A; Alaraj A; Sadeh M; Grigoryan M; Kuybu O; Haussen DC; Sheth SA; Maud A; Cordina SM; Tanweer O; Kan P; Burkhardt JK; Grandhi R; Siddiq F; Hassan AE
    J Neurointerv Surg; 2022 Aug; 14(8):756-761. PubMed ID: 34349013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study of individualized endovascular treatment for symptomatic intracranial atherosclerotic stenosis in patients with ischemic stroke/transient ischemic attack.
    Mao LL; Ma AJ; Liu ZQ; Zhang J; Xu YF; Chen WY; Cao YJ
    Front Neurol; 2022; 13():1057935. PubMed ID: 36530619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thirty-Day and One-Year Outcomes of Endovascular Treatments for Severe Atherosclerotic Stenosis of Intracranial ICA: Results From a Single Center.
    Shen S; Wang Y; He X; Ma N; Gao F; Song L; Sun X; Liu L; Miao Z; Duan H; Mo D
    Front Neurol; 2021; 12():668868. PubMed ID: 34113312
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravascular ultrasound analysis of small vessel lesions treated with the Sparrow coronary stent system: results of the CARE II trial.
    Kume T; Waseda K; Koo BK; Yock PG; Botelho R; Verheye S; Whitbourn R; Meredith I; Worthley S; Hai KT; Honda Y; Abizaid A; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):19-24. PubMed ID: 23413202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting vs. bare metal stents for symptomatic vertebral artery stenosis.
    Song L; Li J; Gu Y; Yu H; Chen B; Guo L; Zhang J
    J Endovasc Ther; 2012 Apr; 19(2):231-8. PubMed ID: 22545889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis - results of a single center study with 100 consecutive patients.
    Rohde S; Seckinger J; Hähnel S; Ringleb PA; Bendszus M; Hartmann M
    Int J Stroke; 2013 Feb; 8(2):87-94. PubMed ID: 22296983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic intracranial vertebral artery atherosclerotic stenosis (≥70%) with concurrent contralateral vertebral atherosclerotic diseases in 88 patients treated with the intracranial stenting.
    Wang ZL; Gao BL; Li TX; Cai DY; Zhu LF; Bai WX; Xue JY; Li ZS
    Eur J Radiol; 2015 Sep; 84(9):1801-4. PubMed ID: 26119803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do drug elution components increase the risk of fracture of sirolimus-eluting stents?
    Kawai T; Umeda H; Ota M; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Naruse H; Matsui S; Ishii J; Hishida H; Ozaki Y
    Coron Artery Dis; 2010 Aug; 21(5):298-303. PubMed ID: 20617542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.
    Ando H; Amano T; Takashima H; Harada K; Kitagawa K; Suzuki A; Kunimura A; Shimbo Y; Harada K; Yoshida T; Kato B; Uetani T; Kato M; Matsubara T; Kumagai S; Yoshikawa D; Isobe S; Ishii H; Murohara T
    Eur Heart J Cardiovasc Imaging; 2013 Oct; 14(10):996-1001. PubMed ID: 23341147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter.
    Obata JE; Nakamura T; Kitta Y; Saito Y; Sano K; Fujioka D; Kawabata K; Kugiyama K
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):E777-87. PubMed ID: 23378231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years.
    Zähringer M; Sapoval M; Pattynama PM; Rabbia C; Vignali C; Maleux G; Boyer L; Szczerbo-Trojanowska M; Jaschke W; Hafsahl G; Downes M; Bérégi JP; Veeger NJ; Stoll HP; Talen A
    J Endovasc Ther; 2007 Aug; 14(4):460-8. PubMed ID: 17696619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.